Xeris Biopharma Holdings, Inc. - COM (XERS)

Historical Portfolio Holders from Q3 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
60.6M
Holdings value Q2 2024
$136M
Value change Q2 2024
+$57.5K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
132
Number of buys Q2 2024
67
Number of sells Q2 2024
-59
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 60.2K $172K +$112K $2.86 1
2024 Q2 60.6M $136M +$57.5K $2.25 133
2024 Q1 60.5M $134M +$1.26M $2.21 140
2023 Q4 59.9M $141M +$3.98M $2.35 118
2023 Q3 55.3M $103M -$2.38M $1.86 110
2023 Q2 55.9M $147M +$17.8M $2.62 103
2023 Q1 49.5M $80.6M -$5.93M $1.63 90
2022 Q4 53.9M $71.6M -$5.4M $1.33 93
2022 Q3 57.3M $89.3M -$3.33M $1.56 97
2022 Q2 59.3M $91.3M +$12.2M $1.54 96
2022 Q1 50.4M $129M +$23.8M $2.56 96
2021 Q4 41M $120M +$118M $2.93 87
2021 Q3 704K $1.73M +$1.73M $2.45 1